Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$320.1M
17M shares
52-week range
$7.18 – $23.63
69% from low
Exchange
NASDAQ
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $9.2M | $65.2M | $12.5M | $13.2M | $21.7M | $30.6M | $92.4M |
| Cost of revenue | $6.5M | $38.8M | $8.9M | $9.5M | $12.9M | $15.2M | $43.6M |
| Gross profit | $2.7M | $26.3M | $3.6M | $3.6M | $8.8M | $15.4M | $48.8M |
| Gross margin | 29.4% | 40.4% | 28.7% | 27.5% | 40.6% | 50.3% | 52.8% |
| R&D | $3.0M | $2.8M | $6.4M | $6.0M | $11.7M | $10.9M | $5.1M |
| Operating income | −$20.8M | −$995.1K | −$56.7M | −$66.0M | −$51.9M | −$48.1M | −$38.1M |
| EBITDA | −$18.6M | −$1.4M | −$209.2M | −$218.0M | −$47.9M | −$51.6M | −$32.2M |
| Net income | −$20.1M | −$1.9M | −$174.0M | −$190.5M | −$62.7M | −$46.3M | −$37.7M |
| Net margin | -218.2% | -3.0% | -1388.4% | -1446.8% | -288.5% | -151.2% | -40.8% |
| EPS (diluted) | -2.73 | -0.26 | -47.04 | -37.57 | -5.58 | -3.64 | -2.68 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $203M | $-3.26 | $-4.22–$-2.10 | 2 |
| 2027 | $319M | $-0.60 | $-1.23–$0.44 | 3 |
| 2028 | $456M | $-0.17 | $-0.18–$-0.16 | 1 |
Forward consensus · source: Financial Modeling Prep
Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
www.prenetics.comNo one on the platform currently holds PRE.
No tracked institution reports a position in PRE as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-11-14 | 1-for-15reverse |
No one on the platform has traded PRE yet.
| $145M |
| — |
| MXCTMaxCyte, Inc. | $1.24 | +0.00% | $133M | — |
| OSUROraSure Technologies, Inc. | $4.50 | +0.90% | $310M | — |
Source: Financial Modeling Prep · peers by sector/industry
$PRE CEO Danny Yeung discusses Prenetics' transition from a COVID-era diagnostics business to a wellness brand, and management's view of the category's market opportunity in our latest CEO Chat: https://buff.ly/HV4PDZs
View on StockTwits ↗New research this week on @Prenetics $PRE #sidotiresearch Read note: http://dlvr.it/TT9cH2 #investing #smallcap #microcap
View on StockTwits ↗$PRE Continues to Post Rapid Growth https://buff.ly/VX7WdKG
View on StockTwits ↗https://marketbeat.com/a/8654885/ $PRE Prenetics Global Q1 Earnings Call Highlights
View on StockTwits ↗$PRE Continues Astounding Growth, While Expanding Product Line https://buff.ly/UD4qC7E
View on StockTwits ↗$PRE Q1 '26 Earnings Results & Recap Prenetics raised its full-year 2026 IM8 revenue guidance to $190 million to $210 million, up from the prior range of $180 million to $200 million. Prenetics projects Q2 2026 revenue to be $46 million to $48 million.
View on StockTwits ↗$PRE installed Brian J. Rosin as Chief Financial Officer of IM8.
View on StockTwits ↗New research today on @Prenetics $PRE #sidotiresearch Read note: http://dlvr.it/TSWppr #investing #smallcap #microcap
View on StockTwits ↗$PRE outlined its complete Bitcoin treasury divestment, selling about 510 BTC.
View on StockTwits ↗$PRE Share Price: $16.62 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $2.12 – $2.62 Target Zone: $3.77 – $4.60 Potential Upside: 67% ROI Time to Expiration: 203 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$PRE initiated at $30 price target. IM8 brand hit $120M ARR in 12 months. Company debt-free with $170M cash. Athlete partnerships structured as equity, not endorsement fees. https://youtu.be/IIfurXL7wtc
View on StockTwits ↗Initiating Coverage of Rapid-Growing $PRE https://buff.ly/216Ezbz
View on StockTwits ↗$PRE Giannis Antetokounmpo is joining IM8 as a global partner and shareholder under a multi-year deal, giving the brand a much bigger athlete face.
View on StockTwits ↗New research today on @Prenetics $PRE #sidotiresearch Read note: https://portal.sidoti.com/company-details/1000550/Prenetics%20Global%20Ltd/1000549/CSR #investing #smallcap #microcap
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 5.5× sales vs its 4.1× historical median P/S.
Fair value ≈ $13.89 · price $18.58 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.